We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.72%
2 Healthcare 11.35%
3 Financials 9.44%
4 Consumer Discretionary 8.31%
5 Communication Services 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BATT icon
5701
Amplify Lithium & Battery Technology ETF
BATT
$124M
$137K ﹤0.01%
10,704
+590
+6% +$8.65K
PBFS icon
5702
Pioneer Bancorp
PBFS
$429M
$137K ﹤0.01%
14,473
+1,559
+12% +$15K
SEV
5703
DELISTED
Sono Group N.V. Common Shares
SEV
$137K ﹤0.01%
54,007
+38,415
+246% +$114K
ACR
5704
ACRES Commercial Realty
ACR
$101M
$136K ﹤0.01%
16,720
-246,500
-94% -$2.22M
DCTH icon
5705
Delcath Systems
DCTH
$584M
$136K ﹤0.01%
42,640
-10,352
-20% -$41.9K
THRD
5706
DELISTED
Third Harmonic Bio
THRD
$136K ﹤0.01%
+7,160
New +$129K
CTV
5707
DELISTED
Innovid Corp.
CTV
$135K ﹤0.01%
50,023
+10,673
+27% +$30.4K
AIRG icon
5708
Airgain
AIRG
$72.6M
$134K ﹤0.01%
18,540
-18,505
-50% -$148K
LINC icon
5709
Lincoln Educational Services
LINC
$912M
$134K ﹤0.01%
24,661
-183
-0.7% -$1.18K
PWOD
5710
DELISTED
Penns Woods Bancorp
PWOD
$134K ﹤0.01%
5,876
-1,793
-23% -$41.2K
OKUR
5711
OnKure Therapeutics
OKUR
$158M
$134K ﹤0.01%
3,989
+1,939
+95% +$63.7K
EVLO
5712
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$134K ﹤0.01%
3,216
-3,762
-54% -$172K
CLSD
5713
DELISTED
Clearside Biomedical
CLSD
$133K ﹤0.01%
7,845
-32,270
-80% -$707K
JMSB icon
5714
John Marshall Bancorp
JMSB
$330M
$133K ﹤0.01%
5,426
+32
+0.6% +$811
ODC icon
5715
Oil-Dri
ODC
$1.3B
$133K ﹤0.01%
11,056
-17,026
-61% -$240K
CYT
5716
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$133K ﹤0.01%
69,334
-146,039
-68% -$381K
UBP
5717
DELISTED
Urstadt Biddle Properties Inc.
UBP
$133K ﹤0.01%
8,466
-3,988
-32% -$66.4K
MTR
5718
Mesa Royalty Trust
MTR
$5.4M
$132K ﹤0.01%
10,477
+800
+8% +$11K
ROIV icon
5719
Roivant Sciences
ROIV
$26.2B
$132K ﹤0.01%
41,164
+14,982
+57% +$58K
SMDD icon
5720
ProShares UltraPro Short MidCap400
SMDD
$1.85M
$132K ﹤0.01%
+2,000
New +$105K
TOON icon
5721
Kartoon Studios
TOON
$38M
$132K ﹤0.01%
21,985
-21,665
-50% -$159K
GLOP
5722
DELISTED
GASLOG PARTNERS LP
GLOP
$132K ﹤0.01%
25,479
+8,335
+49% +$47.3K
KNG icon
5723
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.48B
$131K ﹤0.01%
2,872
+151
+6% +$7.66K
BODI icon
5724
The Beachbody Company
BODI
$50.5M
$131K ﹤0.01%
2,605
+97
+4% +$6.16K
TCRR
5725
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$131K ﹤0.01%
73,248
-76,335
-51% -$221K

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.